an executive R&D management company built on the “united we
stand, divided we fail” concept.
In today’s economy and with the complexity of drug
development and global regulatory requirements, it is impossible for
any one entity to do it all themselves.
At C2C we realize and embrace this and consequently work with
our clients, the regulators, and network of consultants and
preferred service providers to make clinical investigation of your
intellectual property a reality.
What we bring to the table is a fully
integrated drug development team with an aggregate 198
years of pharmaceutical development experience.
When C2C signs a contract, we take full accountability for
your drug development program and will act as your entire
R&D division, removing the need for you to develop this
infrastructure on a full time basis.
C2C will provide your company with a “part-time”
R&D Executive who will be an integral part of your
management team to help define your development strategy, ensure
compliance with global regulatory requirements and make certain the
development is technically sound with execution on time and on
budget. Additionally we
will provide your company with the project management and flexible
capacity not only to advise you but to execute pre-clinical to
clinical proof of concept, technology and site transfers, and
will fill the gaps with experience across the development chain
meeting Quality and CMC objectives.
an executive R&D management company, let us help you:
due diligence and assess opportunities
on development and regulatory strategies
all aspects or any individual element of the execution of your
development or technology transfer plan
your development programs across all service providers to ensure a
comprehensive, cohesive and compliant data package
experts for interactions with regulatory authorities
additional capacity or capability to your organization to meet
expertise to resolve technical issues and ensure quality and
compliance for optimization